Compare BLLN & AXTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLLN | AXTI |
|---|---|---|
| Founded | 2016 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.2B |
| IPO Year | 2025 | 1998 |
| Metric | BLLN | AXTI |
|---|---|---|
| Price | $93.23 | $62.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $129.00 | $91.60 |
| AVG Volume (30 Days) | 561.3K | ★ 5.9M |
| Earning Date | 08-05-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 103.40 | N/A |
| EPS | ★ 0.48 | 0.16 |
| Revenue | ★ $305,112,000.00 | $99,361,000.00 |
| Revenue This Year | $49.05 | $146.79 |
| Revenue Next Year | $26.16 | $111.35 |
| P/E Ratio | ★ $204.98 | $428.16 |
| Revenue Growth | ★ 99.97 | 31.09 |
| 52 Week Low | $61.96 | $4.35 |
| 52 Week High | $150.44 | $143.16 |
| Indicator | BLLN | AXTI |
|---|---|---|
| Relative Strength Index (RSI) | 38.68 | 40.09 |
| Support Level | $88.85 | $53.06 |
| Resistance Level | $98.14 | $72.71 |
| Average True Range (ATR) | 7.14 | 5.41 |
| MACD | -2.29 | -1.83 |
| Stochastic Oscillator | 6.44 | 1.64 |
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.